Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (281-290 of 945) with videos related to

Pageof 95
Sort By:
Diagnostic Microbiology and Infectious Disease|April 1, 1986
Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented mediaR N Jones, A L Barry, C Thornsberry
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 27, 2002
Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS284756 (T-3811) tested against non-fermentative Gram-negative bacilliW Howard, D J Biedenbach, R N Jones
Diagnostic Microbiology and Infectious Disease|March 15, 2001
Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocciR N Jones, M A Pfaller, M Stilwell, et al.
Journal of Clinical Microbiology|February 1, 1984
Interpretive standards and quality control limits for susceptibility tests with ampicillin-sulbactam combination disksA L Barry, R N Jones, C Thornsberry
Antimicrobial Agents and Chemotherapy|April 1, 1980
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strainsC N Baker, C Thornsberry, R N Jones
Reviews of Infectious Diseases|September 1, 1982
Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergyR N Jones, A L Barry, C Thornsberry
The Journal of Antimicrobial Chemotherapy|November 1, 1980
In vitro evaluation of LY127935 (6050S) compared with cefotaxime, eight other beta-lactams and two aminoglycosidesA L Barry, C Thornsberry, R N Jones
Antimicrobial Agents and Chemotherapy|October 1, 1981
Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility testA L Barry, R N Jones, C Thornsberry
Diagnostic Microbiology and Infectious Disease|June 1, 1997
In vitro antimicrobial activity of RU-59863, a C-7 catechol substituted cephalosporinM E Erwin, D Varnam, R N Jones
Diagnostic Microbiology and Infectious Disease|January 1, 1985
In vitro antimicrobial susceptibility testing using 30 microG and 75 microG U63196-E (cefpimizole AC-1370) disksR N Jones, C Thornsberry, A L Barry
Pageof 95

Showing results (281-290 of 945) with videos related to

Sort By:
Pageof 95
Diagnostic Microbiology and Infectious Disease|April 1, 1986
Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented mediaR N Jones, A L Barry, C Thornsberry
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 27, 2002
Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS284756 (T-3811) tested against non-fermentative Gram-negative bacilliW Howard, D J Biedenbach, R N Jones
Diagnostic Microbiology and Infectious Disease|March 15, 2001
Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocciR N Jones, M A Pfaller, M Stilwell, et al.
Journal of Clinical Microbiology|February 1, 1984
Interpretive standards and quality control limits for susceptibility tests with ampicillin-sulbactam combination disksA L Barry, R N Jones, C Thornsberry
Antimicrobial Agents and Chemotherapy|April 1, 1980
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strainsC N Baker, C Thornsberry, R N Jones
Reviews of Infectious Diseases|September 1, 1982
Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergyR N Jones, A L Barry, C Thornsberry
The Journal of Antimicrobial Chemotherapy|November 1, 1980
In vitro evaluation of LY127935 (6050S) compared with cefotaxime, eight other beta-lactams and two aminoglycosidesA L Barry, C Thornsberry, R N Jones
Antimicrobial Agents and Chemotherapy|October 1, 1981
Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility testA L Barry, R N Jones, C Thornsberry
Diagnostic Microbiology and Infectious Disease|June 1, 1997
In vitro antimicrobial activity of RU-59863, a C-7 catechol substituted cephalosporinM E Erwin, D Varnam, R N Jones
Diagnostic Microbiology and Infectious Disease|January 1, 1985
In vitro antimicrobial susceptibility testing using 30 microG and 75 microG U63196-E (cefpimizole AC-1370) disksR N Jones, C Thornsberry, A L Barry
Pageof 95